ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintTitle ChevronIcon Twitter
Politics

China passes biosecurity law to prevent infectious diseases

Medical workers in protective suits collect swabs for nucleic acid tests during a city-wide testing following new coronavirus disease (COVID-19) cases in Qingdao, China Oct. 12.   © Reuters

SHANGHAI (Reuters) -- China's top legislative body passed a new biosecurity law aimed at preventing and managing infectious diseases, state news agency Xinhua reported late on Saturday.

The National People's Congress Standing Committee voted to adopt the law on Saturday, according to Xinhua, and it would come into effect on April 15, 2021.

The law would establish systems for biosecurity risk prevention and control, including risk monitoring and early warning, risk investigation and assessment, and information sharing.

It would also have provisions to prevent and respond to specific biosecurity risks, including major emerging infectious diseases, epidemic and sudden outbreaks, and biotechnology research, development and application, reported Xinhua.

China had announced in May that it aimed to fast-track the passing of the biosecurity law by year-end, following the global coronavirus outbreak which was first detected in the Chinese city of Wuhan.

China has managed to nearly stamp out domestic transmissions of the coronavirus following aggressive measures to curb its spread. New infections detected last week in the eastern coastal city of Qingdao however ended China's run of about two months without reporting a local case.

China's health commission last reported 13 new coronavirus cases in the mainland for Oct. 17, bringing the mainland's total number of confirmed cases to 85,672.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more